ROBERT WINN: Open Payments
NPI 1629096821 · HADDON TOWNSHIP, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$290 in 19 payments from 11 companies in 2025. Trend: 2023 $272 · 2024 $472 · 2025 $290
Food & beverage: $290
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 4 | $58 |
| Indivior Inc. | 3 | $45 |
| ABBVIE INC. | 2 | $35 |
| Gilead Sciences, Inc. | 2 | $32 |
| Merck Sharp & Dohme LLC | 2 | $32 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| ViiV Healthcare Company | 1 | $15 |
| Almatica Pharma LLC | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: BRIXADI, VRAYLAR, PIFELTRO, SUBLOCADE, XIFAXAN, CAPLYTA, APRETUDE, LOREEV XR.
Industry payments across NJ — which companies pay providers there.
